Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence

What is the purpose of this trial?

This study is designed to determine if the drug zonisamide is more effective than placebo in decreasing alcohol use and PTSD symptoms when used in combination with Enhanced Cognitive Processing Therapy (E-CPT-C) in veterans with Post-Traumatic Stress Disorder (PTSD) and comorbid alcohol dependence.

Participation Guidelines

Ages: 21 - 65 years

Gender: Both

Department of Defense

Start Date: 12/13/2012

End Date: 12/31/2015

Last Updated: 06/22/2018

Study HIC#: 1211011063

Get Involved

For more information about this study, contact:
Jenelle Newcomb
+1 203-932-5711

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image


Ismene Petrakis

Principal Investigator